Endometriosis is associated with aberrant gene expression in the eutopic endometrium of women with disease.
INTRODUCTION
Endometriosis is a major cause of infertility and an oftenpainful disease characterized by the presence of endometrial tissue outside the uterine cavity [1, 2] . The disease affects one in 10 women of reproductive age [3] , 50%-60% of women and teenage girls with pelvic pain [4] , and up to 50% of women with infertility [3] .
Multiple factors have been implicated in endometriosisassociated infertility, including significant alterations in the molecular markers of endometrial receptivity in women [5] and baboons [6, 7] . The endometrial transcriptome, cellular signaling, and biochemical pathway modulation differ in the endometrium from women with endometriosis from those of disease-free women [5, 8] . Comparison of the eutopic endometrial transcriptome of women with moderate and severe disease and those without disease reveals differences in all phases of the menstrual cycle but primarily in the proliferative, early secretory, and midsecretory phases, with a persistence of the proliferative phenotype and enhanced cell survival in disease [5] . The attenuated progesterone response in the midsecretory phase of women and baboons with endometriosis is reflected in the altered expression of progesterone-regulated genes [5, 6, 9] . Using our baboon model, we propose that following the establishment of endometriosis, the eutopic endometrium undergoes an early coordinated series of aberrant changes during the window of uterine receptivity compared to disease-free controls, similar to those observed in human endometrium in the setting of existing endometriosis.
To date, a vast numbers of eutopic gene arrays have been investigated in women with a history of established disease at clinical presentation. These women carry a heavy disease burden and/or a disease load that is poorly defined due to extensive time to diagnosis. As such, it is not possible to clearly demonstrate that the aberrant gene expression that has been reported is a product or consequence of endometriosis.
We and others have developed the baboon (Papio anubis) as a model for the study of endometriosis [10] [11] [12] . Our model allows a tightly controlled environment of experimentally induced endometriosis in baboons with documented regular menstrual cycles. Intraperitoneal inoculation with autologous menstrual endometrium results in the formation of endometriotic lesions in the baboons with histological and morphological characteristics similar to those in women [13] . Individual differences in progression and symptoms of the disease create difficulties in conducting objective long-term studies in women. Furthermore, endometriosis only occurs naturally in humans and nonhuman primates.
Previously, we performed a small-scale microarray to determine if immunological aberrations were evident in the eutopic endometrium of baboons 6 mo following experimental induction of endometriosis [14] . In the current study, we have performed extensive microarray analysis using the Affymetrix Gene Arrays to examine changes in eutopic endometrial gene expression during the development of experimental endometriosis in baboons from 1 to 15-16 mo after disease; the expression pattern was then compared to that in disease-free model and subsequently in baboons with spontaneous endometriosis.
MATERIALS AND METHODS

Animals and Induction of Experimental Endometriosis
All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Illinois, Chicago, and Michigan State University. Endometriosis was experimentally induced in four female P. anubis baboons by intraperitoneal inoculation with menstrual endometrium on two consecutive menstrual cycles, as previously described [7] . Animals were nulliparous with documented regular menstrual cycles and had not undergone any previous surgeries. Two baboons with spontaneous endometriosis were included in this study with an unknown duration of disease. Menstrual endometrium was harvested on Days 1-2 of menses using a Unimar Pipelle (Cooper Surgical Inc., Shelton, CT) immediately prior to laparoscopy. Under laparoscopic guidance, approximately 1 g of menstrual tissue and fluid was deposited from the Pipelle at four sites: the pouch of Douglas, the uterine fundus, the cul de sac, and the ovaries. At the subsequent mense, the animals underwent a second laparoscopy and endometrial reseeding at the same ectopic sites. The progression of disease was monitored in each animal by consecutive laparoscopies and video recording at 1 (n ¼ 2), 3 (n ¼ 4), 6-7 (n ¼ 4), 10-12, (n ¼ 4), and 15-16 (n ¼ 3) mo after inoculation during the window of uterine receptivity (Days 9-11 postovulation [PO] in the baboon [ Fig. 1]) . After laparoscopic entry, a complete systemic survey of the abdomen and pelvic cavity was performed, and the number, color, and position of each visible lesion were digitally documented [15] . The presence of peritoneal fluid, extent of adhesions, level of surface vasculature, scar tissue, and corpora lutea were noted. Following each laparoscopy, a laparotomy was performed, and eutopic endometrial tissue was harvested [13] . Unlike in women where endometrial biopsies yield sufficient tissue for analyses, in baboons we obtain only a very limited amount of tissue with pipelle biopsies, primarily due to the size of the uterus. Therefore, in order to utilize a valuable animal model to its fullest extent, we obtain endometrial tissue following laparotomy using a procedure referred to an endometriectomy, which yields the most amount of tissue to maximize our analyses [12] . At 15-16 mo following the second inoculation, the animals were euthanized as required by the IACUC approval, which permits a maximum of four invasive surgeries, and a necropsy was carried out to obtain all of the associated reproductive tissues within the peritoneal cavity.
Collection and Processing of Tissue
Blood samples were collected daily from Days 7 through 16 postmenstruation of menstrual cycles, during which surgery was performed. Serum estradiol (E2) was measured by radioimmunoassay (DSLabs, Webster, TX). The serum E2 peak was taken as Day À1 of ovulation, and the day of ovulation was designated as Day þ1 [16] . Eutopic endometrial tissues were harvested between Days 9 and 11 PO and were snap frozen in liquid nitrogen for RNA extraction. Eutopic endometrium from the functionalis layer was consecutively harvested by endometriectomy from the same animals following experimental induction of endometriosis (Fig. 1) .
Disease-Free Control Animals
Control endometrium was similarly harvested from animals (n ¼ 4) with no previous surgeries and with no visible disease between Days 9 and 11 PO. Disease-free (DF) control animals were subjected to laparotomies. Laparoscopy was done prior to the laparotomy to confirm the complete absence of spontaneous endometriosis in the control animals [15] .
Microarray
Eutopic endometria were homogenized in TRI-ZOL reagent (Invitrogen, Carlsbad, CA), and RNA was extracted. Total RNA was then subjected to DNase digestion to remove genomic DNA and was purified using the RNeasy Kit (Qiagen, Valencia, CA). RNA purity was confirmed by 260/280-nm absorbance ratios and analysis on an Agilent Bioanalyzer, following which cDNA was prepared according to the Affymetrix microarray preparation protocol (Affymetrix, Santa Clara, CA). Individual samples were hybridized to Affymetrix Human Genome U133 Plus 2.0 Arrays and scanned using an HR3000 scanner and data were extracted using the Affymetrix Gene-Chip Operating System V1.1.
FIG. 1. Endometriosis was experimentally induced in female
Papio anubis (baboons) with documented regular menstrual cycles by intraperitoneal inoculation with menstrual endometrium. Endometrium was harvested on Days 1-2 of menses immediately prior to laparoscopy. At the subsequent mense, the animals underwent a second laparoscopy and endometrial reseeding at the same ectopic site, the uterine fundus, the cul de sac, the ovaries, and the pouch of Douglas. Following each laparoscopy, a laparotomy was performed, and eutopic endometrial tissue was harvested. The progression of disease was monitored in each animal by consecutive laparoscopies at 1 (n ¼ 2), 3 (n ¼ 4), 6 (n ¼ 4), 9-12 (n ¼ 4), and 15-16 (n ¼ 4) mo after inoculation, during the window of uterine receptivity (Days 9-11 postovulation [PO] in the baboon). At 15-16 mo following the second inoculation, the animals were euthanized, and a necropsy was carried out to obtain all of the associated reproductive tissues within the peritoneal cavity.
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Microarray Analysis
The gene expression data were normalized and background corrected with the Robust Multichip Average method [17] using R/Bioconductor [18] . Nonspecific filtering was performed by obtaining the overall variability of each probe set across arrays. Probe sets with low variability between different time points were safely discarded since they do not add value in the inference of differential expression of their target genes [19] . To find differentially expressed probe sets, the limma package in R/Bioconductor was utilized [20] . Limma uses linear models to analyze a designed experiment and to determine differential expression [21] . To determine the linear coefficients of the model, a design matrix was created that included a coefficient for the difference of samples between time points, and a moderated t-statistic was used. The P value for each probe set was then corrected with the BenjaminiHochberg algorithm for multiple hypothesis testing [22] . This method controls the expected false discovery rate and probe sets with an adjusted P value of ,0.05 were considered differentially expressed.
Probe sets were mapped to unique Entrez Gene IDs using a custom Chip Description File (CDF) [23] . The R package ''HGU133A_Hs_ENTREZG'' version 13.0 (July 2010) was used in this analysis, as it provided the most current mapping between probe sets and gene Entrez IDs for the Affymetrix Human Genome U133 Plus 2.0 microarray.
Fold change, as the sole criterion for differential expression, does not provide a probabilistic estimation of the significance of the variations in gene expression. The normalization of the expression data, the use of a moderated ttest, and the posterior correction for multiple hypothesis testing are robust methods to obtain a list of differentially expressed genes based on the significance level of our choice (0.05). Differential expression analysis was conducted in samples between consecutive time points, such as 1 mo versus control, 3-6 mo versus 1 mo, and so forth, including the analysis of gene expression in animals with spontaneous disease versus all other time points.
Subsequently, both Ingenuity Pathways Analysis (IPA) and pathway and GO term enrichment with DAVID Bioinformatics [24] were input with the lists of differentially expressed genes between time points. These tools allowed us to identify any statistically significant enrichment of GO terms or molecular pathways between the two biological states represented by samples of different time points. Principal components analysis (PCA) and hierarchical clustering were applied to the normalized expression values of all genes in all samples. A dendrogram was added to the heat maps to illustrate the output of the hierarchical clustering. The dendrogram marks the inter-cluster distance between the different clusters. Samples whose genes have similar expression patterns clustered together.
RESULTS
Clustering Analysis
PCA is frequently used to reduce the dimensionality of a data set by reporting the principal components that accumulate the largest variance. PCA of all samples in a microarray experiment provides insights into the expression profiles of the genes in each sample. As a result of this, samples that have similar gene expression profiles cluster closely together. In our analysis, samples clustered into two major groups (Fig. 2) . When we consider the average expression values of genes at each time point, the PCA clearly separates the average expression profiles by disease time point ( Fig. 2A) . The Xaxis accumulates 71% of the variance and provides a clearer picture of the two main clusters situated to the left and right of the chart. The Y-axis is the second principal component, wherein the DF control animals and the early and transitional stages are separated from the M10-12 and M15-16 of disease.
In a similar manner, the average expression profiles of all genes at each time point, including four samples from DF control animals, were used for an unfiltered hierarchical clustering analysis. The average profiles self-segregated into two major groups. Hierarchical clustering demonstrated similarities in eutopic endometrial transcriptome between animals at 1, 3, and 10-12 mo of disease (Fig. 2B) . Pairwise comparisons between dysregulated transcripts at 1, 3, and 10-12 mo of disease revealed striking similarities. The second cluster was comprised of samples from animals at 6-7 (n ¼ 4) and 15-16 (n ¼ 4) mo following induction of disease, together with those from DF control animals (n ¼ 4). Animals with spontaneous disease (n ¼ 2) and labeled as S1 and S2 clustered with those at 6-7 and 15-16 mo of induced disease (Fig. 2C) .
The hybridization efficiency of baboon cRNA to a human array platform was investigated (Supplemental Figure S1 ; all Supplemental Data are available online at www.biolreprod. org). The number of detectable probes in each sample indicated a hybridization efficiency ranging from 18% to 39%, well within that expected for any human sample [25] . However, Animal 7024 (induced disease) displayed a low hybridization efficiency of less than 10% and was excluded from further analysis. Morphologically, 32 of the 48 (67%) ectopic lesions harvested contained both endometrial glands and stroma (data not shown). The disease burden was similar between animals, and we observe an average of nine lesions per animal at each laparoscopy. The majority of the lesions found 1 mo following tissue inoculation are red lesions, which change color during the disease progression. In addition, new lesions are continuously developing, and they persist up to 15 mo postinoculation [15] .
Early Disease Burden
Within only 1 mo of disease induction, pairwise comparisons of eutopic endometrium demonstrated 4331 genes that were differentially expressed compared to DF animals in the eutopic endometrium. Very early after induction of disease, this large-scale dysregulation of the endometrial transcriptome was observed; 2201 genes were exclusive to the 1-mo time frame without redundancy at other time points. The largest number of members in a gene family, 17, were altered in the modulator of nonspecific immunity, nucleotide oligomerization domain-like receptors [26] , within 1 mo of disease, compared to controls (Supplemental Figure S2) [27] . Between no other time points of disease, 3, 6-7, 10-12, and 15-16 mo following inoculation, was the differential gene expression as robust as at 1 mo ( Fig. 3 and Table 1 ). A significant lack of differential regulation of the endometrial transcriptome was observed in the same animals 2 mo later or 3 mo following induction of endometriosis, whereby zero genes were differentially expressed among time points. Of note, the pairwise comparisons between DF controls and spontaneous disease demonstrated a significant gene modulation of 4032 genes.
Transitional Response
In comparisons between control and 6-7 mo of disease, only one gene, the proto-oncogene FOS, was differentially expressed, marking the dominance of the estrogenic phenotype. Between time points 3 to 6-7 and 6-7 to 10-12 mo of disease, 1803 and 1893 genes, respectively, were differentially expressed, P , 0.05; 170 genes were exclusive to the 3-to 6-7-mo transition and 266 genes to the 6-7-to 10-12-mo transition, and 92 genes overlapped between the transitions of these three time points. All other differential expression was shared with the 1-mo to control group (Fig. 3) . BIOCARTA analysis demonstrated enrichment of differential expression with the five members of the costimulatory signal during T-cell activation-Cd3d, Icoslg, Pik3R1, HLA-DRA, and CD28-between M6-7 and M10-12 (Supplemental Table S1 ).
Late Response
Comparing differential gene regulation directly between the final two time points, 10-12 and 15-16 mo of disease, there are minimal alterations in the genetic signature of the endometrium. Only two genes, Interferon regulatory factor 2 (IRF2) and adipoQ receptor family member III (Paqr3), are differentially expressed compared to DF controls, P , 0.05 (Supplemental Table S2 ). To elucidate the pattern of differential gene regulation in the eutopic endometrium of baboons over a 15-16-mo period following induction of endometriosis, no correlations were significant with disease load [15] . The level of gene dysregulation did not correlate with the number of lesions present or the type of lesion or the position of lesion present at each time point (Fig. 4) .
Canonical Pathways and Networks Through Disease
Pathway analysis (KEGG and BIOCARTA) using DAVID Bioinformatics [24, 28] provided a means to quantitatively present pathways differentially modulated throughout the time course of disease. KEGG analysis demonstrated neuroactive ligand-receptor interaction (73 members, adjusted P value ,5.82E-03), tyrosine metabolism, tight junction, cysteine and methionine metabolism, and leukocyte transendothelial migration. BIOCARTA points to PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase and the role of myelin and lymphocyte protein in rho-mediated activation of serum response factor (Supplemental Table S1) IPA evaluated the changes of the genes in disease versus control at 1, 3, 6-7, 10-12, and 15-16 mo. The degree of regulation of signaling pathways and network formations in different comparison groups depends on the total number of genes regulated in each group. Significantly regulated network functions and canonical pathways formations are demonstrated in Tables 2 and 3 .
The IPA software uses computational algorithms to identify cellular networks that statistically fit the input gene list and expression values from experiments. Data sets containing the Affymetrix probe identifiers and fold changes of genes were overlaid on global molecular networks that were developed from connectivity information. Networks were then algorithmically generated, and a score was assigned. The score is used to rank networks according to how relevant they are to the genes in the input database demonstrating reproductive system development and function, cancer, and reproductive system disease as the second-highest IPA score behind cell cycle, cardiac necrosis, and cell death ( Table 2) . Of note, a predominant associated network function included both reproductive system development and function (Table 3 ; score: 31, P ¼ 7.6E-04 À 1.4E-02, 21 molecules).
Canonical pathways analysis identified the pathways that were most significant to the input data set. The significance of association was determined based on the ratio of the gene number from the data sets that maps to pathways divided by the total number of genes that map to the canonical pathways, and a P value was calculated using the Fischer exact test, which determined the probability that the association between the genes in the data set and the canonical pathway is due only to chance. Each network of pathways was set to have a maximum of 30 focus genes. Genes or gene products are represented as nodes, and the biological relationship between two nodes is represented as an edge. The intensity of the node color indicates the degree of up-regulation (red) or down-regulation (green). IPA demonstrated that during disease progression, several signaling pathways were significantly affected in a dynamic time-specific manner, namely, PI3K/AKT, EGF, and ERK signaling (Supplemental Figures S3-S5 ).
Pathway Analysis Reveals Altered EGF Signaling Profile in Baboons with Endometriosis
The EGF signaling pathways demonstrated key genes of interest, including Fos, Map2k7, Jak1, June, Pik3c2a, Mapk3, Pik3cg, Plcg1, Stat1, and Mig6. Egfr, together with Pi3k and Stat3/Stat3-P, was down-regulated following disease induction (Table 4 and Supplemental Figure S3 ). We observed dysregulation of several antiproliferative genes in the EGF signaling cascade. Mitogen-inducible gene 6 (Mig6) functions as a negative regulator of EGF mitogenic signaling, and here we demonstrate that the gene is elevated at 15-16 mo of disease and low in the early disease process, consistent with human data that noted an increase in Mig6 in women with long-term disease [5] . Additionally, Fos was the single gene that was differentially regulated between DF controls and 6-7 mo of disease, consistent with our previously published data [14] .
Pathway Analysis Reveals Altered PI3K/AKT Signaling Profile in Baboons with Endometriosis
Induction of disease immediately affects the PI3K/AKT signaling in baboons with endometriosis. After 1 mo of disease burden, a number of PI3K/AKT pathways genes are modulated, including Jak1, Mapk3, Ywhaz, Pdpk1, Kras, Mdm2, Ikmke, Lims1, Jak2, Inpp5d, Bcl2, Pten, Ppp2cb, Gab1, Ppp2r3a, Pik3cg, Ppm1j, Ppm1l, Ppp2r2b, HLA-B, Rheb, Itga4, and Them4 (Table 4 and Supplemental Figure S4 ). Of note, the progesterone receptor-mediated signaling pathways are attenuated at 6-7 mo of disease, confirming that the 
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endometrium is less responsive to progesterone as a consequence of endometriosis [29] [30] [31] .
Pathway Analysis Reveals Altered ERK/MAPK Signaling Profile in Baboons with Endometriosis
Our data to date suggest that the eutopic endometrium undergoes sequential changes that are initially characterized by a dominance of E2-regulated genes early on in disease such as FOS. Significantly, the ERK/MAPK signaling pathways [32] are differentially expressed during disease progression. These genes include Fos, Mapk3, H3f3b, Pla2g2a, Ppp1r3a, Kras, Ksr1, Ppm1j, Pik3cg, Ppm1l, Mknk1, Stat1, Itga4, Pla2g12a, Pik3c2a, Ywhaz, Plcg1, Nfatc1, Pla2g4c, Ppp2cb, Elf2, Araf, Ppp2r3a, Ppp2r2b, Prkag2, and Esr as are described in the time course (Table 4 and Supplemental Figure S5 ).
Baboon Model Confirms Candidate Gene Susceptibility in Women with Endometriosis
Cross-referenced [5] pairwise hierarchical analysis with our baboon data as early as 1 mo following induction of disease confirmed significant overlap with women with endometriosis. Burney et al. [5] report 721 human genes significantly differentially expressed in the eutopic endometrium of endometriosis compared to controls: 428 were up-regulated and 293 down-regulated at least 1.5-fold. Significantly, 278 genes, or 38.6%, overlapped in our baboon model of endometriosis. An additional 72 genes were significantly differentially expressed between human and baboon spontaneous disease (Supplemental Table S3 ). Intriguingly, a number of midsecretory phase candidate genes that are dysregulated in women with endometriosis [5] were also differentially expressed following disease induction in the baboon, further validating this model. These genes include Sugcl2, S100a1, Cdkn2b, Cyp26a1, Muc3b, Rin3, Paqr3, and Nodal, which were differentially regulated throughout the course of the disease. Additionally, this overlap between the baboon and human data extended to pathways detailed above (Supplemental Table S3 ).
DISCUSSION
The experimental induction of endometriosis in female baboons continues to establish the baboon as a viable, nonhuman primate model for endometriosis research, providing insight into the pathophysiology of a disease that affects up to 50% of women with infertility [33] . Progression of disease was monitored in our animals by consecutive laparoscopies over a period of 15-16 mo after peritoneal inoculation occurring during the window of uterine receptivity (Days 9-11 PO in the baboon). Inoculation of menstrual endometrium resulted in the formation of endometriotic lesions with both gross morphological and histological characteristics similar to those seen in women [13] . The development of these endometriotic lesions was observed in all animals that underwent intraperitoneal inoculation. Progression of disease with changes in the eutopic endometrmetrial transcriptome as early as 1 mo after disease was associated with the establishment and maintenance of endometriotic lesions in the peritoneal environment.
Although retrograde menstruation occurs in 70%-90% of women in the reproductive age group, endometriosis is diagnosed in only 10% of this population [3, 34] . This suggests that endometriosis is a consequence of an inherent endometrial defect or a genetic predisposition. Surgical removal of endometriotic lesions as well as treatment with gonadotropin-releasing hormone (GnRH) analogs improve pregnancy rates in patients with endometriosis [35] [36] [37] [38] . Lessey et al. [39] reported improvement in fertility observed in women with endometriosis treated with GnRH analogs and subsequent ablation of endometriotic foci. These data support the theory that an inherent endometrial dysfunction could be associated with the reduced pregnancy rates, secondary to failed implantation, in women with endometriosis.
Within only 1 m following disease induction, 4331 genes were differentially expressed in the eutopic endometrium   FIG. 4 . After laparoscopic entry, a complete systemic survey of the abdomen and pelvic cavity was performed, and the number of each visible lesion (A) and lesion location (B) was documented. At 15-16 mo, a hysterectomy and necropsy were performed, and all lesions were documented. The total number of lesions at each time point was not significantly different until the 15-16-mo time point (**P , 0.05), which is the time point at which all lesions are visualized and documented in the laboratory following complete removal of all tissues. compared to disease-free controls, implying a direct and acute interaction between the presence of ectopic endometriotic lesions and alterations in uterine gene signature and possibly uterine receptivity. Endometrial gene signatures, at different time points, self-segregated into clusters (Fig. 2) . Differentially expressed genes in the baboon showed a high correlation with aberrant gene expression in endometrium of women with endometriosis (Supplemental Table S3 ).
The strength of this study lies in the ability to document the early disease process that cannot be captured in the human disease, as we have the ability to document the exact length of disease in baboons. The baboon model allows us to directly determine how the presence of ectopic lesions directly impacts eutopic gene expression as early as 1 mo after the disease and monitor the dynamic alteration of the gene signature during the progression of the disease. Our data demonstrate that the molecular changes in the eutopic endometrium associated with endometriosis directly impacts endometrial function and provides strong evidence that it is the presence of the lesions that results in aberrant a ''waxing-waning'' pattern of gene expression in the eutopic endometrium during disease progression. We speculate that although the lesion numbers do not change significantly during the time course of the disease (Fig. 4 [12] ), the waxing-waning pattern of gene expression we observe may be associated with periods of uterine quiescence that may be conducive to pregnancy. Many functional clues can be gained from looking at individual genes and global gene expression changes in microarray data at set statistical parameters. Genes or gene products are represented as nodes, and the biological relationship between two nodes is represented as an edge with the intensity of the node color indicates the degree of up-regulation (red) or down-regulation (green) could then be followed through time (Supplemental Figures S3-S5 ). The EGF signaling pathway is significantly modulated in our model; members include Fos, Egfr, and Mig6, among others. Fos encodes the protein c-Fos, a member of the AP-1 family of proteins, which play a critical role in controlling cell death [14] . AP-1 can act as a transcriptional activator, or repressor [40] . Fos is up-regulated 10-26-fold in the eutopic endometrium of baboons with endometriosis at 3 mo and decreased by 93-and 60-fold over controls at 6 and 10-12 mo, respectively. Fifteen months after induction of endometriosis, levels of Fos mRNA expression were similar to those found in control tissues from animals with no disease [14] . Furthermore, Fos has been shown to inhibit progesterone receptor (PR)-induced transcription [41] . We have proposed that in the very early stages of the disease, when the levels of PRA are similar in eutopic endometrium of induced animals and controls, increased levels of Fos may inhibit the ability of PRA to mediate the transcription of progesterone-regulated genes [42] . This interaction would provide another mechanism whereby PRA activity is inhibited; in contrast, estrogen receptor (ESR)-induced genes such as MMPs, Vegf, and Cyr61 are expressed in the eutopic endometrium during the window of receptivity at the early stages of the disease, when we also observe the greatest change in global gene expression, even though there are no significant differences in the expression level of steroid hormone receptors during the early phase of the disease [13, 43, 44] .
It has been demonstrated that the absence of Mig6 results in the inability of progesterone to inhibit estradiol-induced uterine weight gain and estradiol-responsive target gene expression [45] . Mig6, also known as Erffi1 (ERBB receptor feedback inhibitor 1), regulates the duration of MAPK activation by attenuating EGFR autophosphorylation [46] . Murine genetic studies have demonstrated that this gene is a critical regulator of endometrial response to estradiol in regulating tissue homeostasis [47] . Furthermore, down-regulation of Mig6 may be associated with conferred survival advantage of the refluxed endometrium and lead to the establishment of endometriotic lesions [48] as it becomes constitutively expressed in endometriosis and results in an increase in mitogenic signaling.
We demonstrate that the eutopic endometrium exhibits molecular abnormalities. It has been previously demonstrated the eutopic endometrium demonstrates the activation of oncogenic pathways like the rat sarcoma viral oncogene homologue (Ras) [2] . Activating K-ras mutations have also been identified in rodent models of endometriosis [49] and women with disease [31] . A screen of women with endometriosis demonstrated a polymorphism in a let-7 micro-RNA (miRNA) binding site in the 3 0 -UTR of Kras and detected a Kras variant allele in 31% of women with endometriosis as opposed to 5% of a large diverse control population. Inherited polymorphism of a let-7 miRNA binding site in Kras leads to abnormal endometrial growth and endometriosis. The LCS6 polymorphism has been described as a genetic marker for endometriosis risk [31] . Among other tumor suppressors and oncogenes, the candidate genes Kras and Pten have been implicated [50] . Of note, Ywhaz in the endometrium is differentially regulated in our baboon model PI3K/AKT signaling  JAK1, MAPK3, YWHAZ, PDPK1, KRAS, MDM2, IKBKE, LIMS1, JAK2, INPP5D, BCL2, PTEN, PPP2CB, GAB1,  PPP2R3A, PIK3CG, PPM1J, PPM1L, PPP2R2B, HLA-B, RHEB, ITGA4, THEM4  ERK/MAPK signaling  MAPK3, H3F3B, PLA2G2A, PPP1R3A, KRAS, KSR1, PPM1J, PIK3CG, PPM1L, MKNK1, STAT1, ITGA4,  PLA2G12A, PIK3C2A, YWHAZ, PLCG1, NFATC1, PLA2G4C, PPP2CB, FOS, ELF2, ARAF, PPP2R3A,  PPP2R2B, PRKAG2, ESR1  EGF signaling  FOS, MAP2K7, JAK1, JUN, PIK3C2A, MAPK3 , PIK3CG, PLCG1, STAT1 
ENDOMETRIOSIS-INDUCED CHANGES IN ENDOMETRIAL GENE EXPRESSION
(Joshi and Fazleabas, unpublished data) and is a target of micro-RNA 451 [51, 52] . Bcl2 and a family of pro-and antiapoptotic family members couple to the PI3K/AKT signaling cascade and provides further evidence of apoptotic resistance and enhanced survival of endometrial cells in endometriosis [53] . We have previously demonstrated high levels of Mmp7, Vegf, Cyr61, and Fos along with an altered distribution of steroid hormone receptors in both the ectopic and the eutopic endometrium of these animals [7, 42, 43, 54, 55] . The increased expression of MMPs and angiogenic factors in both the eutopic and the ectopic endometrium, coupled with the high expression of estrogen receptor (ESR), as demonstrated in the ERK/MAPK signaling profile, has been speculated to allow the endometrial fragments to rapidly attach and invade through peritoneal surfaces to establish lesions. Furthermore, inhibition of MMPs in rodent and primate models suppressed the development of lesions both in vivo and in vitro [56] [57] [58] [59] [60] [61] and angiogenesis [62] [63] [64] .
A disadvantage of our study is that we could not follow pregnancy rates in the animals because of a necropsy needing to be performed at the end of the study and the limitation of statistical power in a small group of animals. Similar to women, baboons with endometriosis have lower pregnancy rates [65, 66] . A further limitation of this study was that control tissues were collected only at a single time point and not at consecutive time points to match the time points of the disease process. There is always the possibility that consecutive laparoscopies followed by endometriectomies could alter the pattern of gene expression, but in the context of this study it is unlikely that the multiple surgeries would have influenced our results since we observe the greatest change in gene expression at 1 mo following disease induction when the animals have not had a single laparotomy.
Using a well-established nonhuman primate model, we have demonstrated that the presence of endometriotic lesions results in an altered eutopic endometrial environment very early in the disease process. By sequential analysis of the eutopic endometrium in the same animals during the progression of the disease, we have also demonstrated that early in the disease process there is a transitory dominance of an estrogenic phenotype, but as the disease progresses a more permanent progesterone-resistant phenotype results concomitant with previously established human disease patterns [5, 30] .
